Literature DB >> 2088727

Expression of the N-myc proto-oncogene during the early development of Xenopus laevis.

P D Vize1, A Vaughan, P Krieg.   

Abstract

The N-myc proto-oncogene is expressed in a wide range of tissues during mammalian embryogenesis. This observation, along with the oncogenic capacity of this gene, has led to the suggestion that N-myc plays an important role in early development. However, due to the complexity of the expression pattern and the difficulty of manipulating mammalian embryos, little progress has been made towards understanding the developmental function of this gene. To enable a more detailed analysis of the role of this gene in early development, a study of the Xenopus homologue of N-myc was undertaken. Xenopus N-myc cDNA clones were isolated from a neurula library using a murine N-myc probe. Analysis of the timing of expression of N-myc mRNA and of the distribution of N-myc protein during Xenopus development indicate that this gene may be playing an important role in the formation of a number of embryonic structures, including the nervous system. N-myc is initially expressed as a maternal RNA, but this mRNA is degraded by the gastrula stage of development. Zygotic expression does not commence until late neurula. Examination of the distribution of the N-myc protein by whole-mount immunohistochemistry indicates that the early embryonic expression occurs in the central nervous system, the neural crest, the somites and the epidermis. Later expression is mostly within the head and somites. Specific structures within the head that express the protein include the eye, otic vesicle, fore and hindbrain and a number of cranial nerves. The results demonstrate that while N-myc is expressed in the developing nervous system of Xenopus, the timing of expression indicates that it is unlikely to be involved in regulation of the very first stages of neurogenesis.

Entities:  

Mesh:

Year:  1990        PMID: 2088727     DOI: 10.1242/dev.110.3.885

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  8 in total

Review 1.  The genus Xenopus as a multispecies model for evolutionary and comparative immunobiology of the 21st century.

Authors:  Jacques Robert; Nicholas Cohen
Journal:  Dev Comp Immunol       Date:  2011-01-28       Impact factor: 3.636

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

3.  Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype.

Authors:  N Schreiber-Agus; D Stein; K Chen; J S Goltz; L Stevens; R A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  The amplification of oligonucleotide themes in the evolution of the myc protooncogene family.

Authors:  J Doskocil
Journal:  J Mol Evol       Date:  1996-05       Impact factor: 2.395

5.  Expression of cyclin D1, cyclin D2, and N-myc in embryos of the direct developing frog Eleutherodactylus coqui, with a focus on limbs.

Authors:  Kimberly Nath; Cara Fisher; Richard P Elinson
Journal:  Gene Expr Patterns       Date:  2013-03-07       Impact factor: 1.224

6.  Comparative analysis of the expression and oncogenic activities of Xenopus c-, N-, and L-myc homologs.

Authors:  N Schreiber-Agus; R Torres; J Horner; A Lau; M Jamrich; R A DePinho
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

7.  Zebra fish myc family and max genes: differential expression and oncogenic activity throughout vertebrate evolution.

Authors:  N Schreiber-Agus; J Horner; R Torres; F C Chiu; R A DePinho
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

8.  Pou5f1/Oct4 promotes cell survival via direct activation of mych expression during zebrafish gastrulation.

Authors:  Kay Kotkamp; Esther Kur; Björn Wendik; Bożena K Polok; Shifra Ben-Dor; Daria Onichtchouk; Wolfgang Driever
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.